n/a 0.0 0.0%
Last Trade -
| Market Cap | £n/a |
| Enterprise Value | £n/a |
| Revenue | £199.9m |
| Position in Universe | th / 6850 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010E | 2011E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 63.0 | 70.9 | 94.7 | 134.4 | 175.1 | 224.2 | +28.9% | ||||
| -37.3 | ||||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
ReSearch Pharmaceutical Services Inc. is a United States based company. The Company is a provider of outsourcing Clinical Development Solutions, provides Phase I-IV services. It provides a project based delivery solution with market full service processes and tools. Its embedded solutions are designed for pipeline portfolio management of large and mid-size customers. Its Hybrid solutions are designed for portfolio management of mid-sized customers. The Company’s full-service clinical outsourcing solutions are designed for project and program-level outsourcing.
| Last Annual | December 31st, 2009 |
| Last Interim | September 30th, 2010 |
| Incorporated | January 30, 2006 |
| No. of Shareholders: | 101 |
| No. of Employees: | 2,185 |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | NASDAQ Global Market |
| Shares in Issue | 37,264,215 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Suite 400 4130 Parklake Avenue, FORT WASHINGTON, 27612, United States |
| Web | http://www.rpsweb.com |
| Phone | +1 919 7868200 |
| Contact | () |
| Auditors | Ernst & Young LLP |
As of , shares in ReSearch Pharmaceutical Services Inc are trading at n/a, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.
Shares in ReSearch Pharmaceutical Services Inc are currently trading at n/a and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the ReSearch Pharmaceutical Services Inc price has moved by % over the past year.
There are no analysts currently covering ReSearch Pharmaceutical Services Inc.
ReSearch Pharmaceutical Services Inc is scheduled to issue upcoming financial results on the following dates:
ReSearch Pharmaceutical Services Inc does not currently pay a dividend.
ReSearch Pharmaceutical Services Inc does not currently pay a dividend.
ReSearch Pharmaceutical Services Inc does not currently pay a dividend.
To buy shares in ReSearch Pharmaceutical Services Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in ReSearch Pharmaceutical Services Inc are currently trading at n/a, giving the company a market capitalisation of £n/a.
Here are the trading details for ReSearch Pharmaceutical Services Inc:
We were not able to load our ranking data for ReSearch Pharmaceutical Services Inc
We were not able to load any forecast data for ReSearch Pharmaceutical Services Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ReSearch Pharmaceutical Services Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of n/a, shares in ReSearch Pharmaceutical Services Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for ReSearch Pharmaceutical Services Inc.
We were unable to find the directors for ReSearch Pharmaceutical Services Inc.
Here are the top five shareholders of ReSearch Pharmaceutical Services Inc based on the size of their shareholding:
